Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-040421
Filing Date
2020-07-02
Accepted
2020-07-02 16:49:41
Documents
2
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1615
2 POA DOCUMENT poa.txt EX-24.3_926206 3082
  Complete submission text file 0001209191-20-040421.txt   6133
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PERSONALIS, INC. 1330 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Musil Clinton (Reporting) CIK: 0001779886 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 201010292